Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Pharmacological Research|April 21, 2019
Drugs and hepatic transporters: A reviewAlexander Jetter, Gerd A Kullak-UblickBiological Psychiatry Global Open Science|May 1, 2023
Toward a Unifying Account of Dopamine's Role in Cost-Benefit Decision MakingAlexander Soutschek, Alexander Jetter, Philippe N ToblerClinical Pharmacokinetics|May 25, 2006
How may anticancer chemotherapy with fluorouracil be individualised?Su-arpa Ploylearmsaeng, Uwe Fuhr, Alexander JetterNutrition & Metabolism|October 8, 2016
Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intakeEmily Urry, Alexander Jetter, Hans-Peter LandoltBasic & Clinical Pharmacology & Toxicology|September 1, 2005
Assessment of CYP1A2 activity in clinical practice: why, how, and when?Mirko S Faber, Alexander Jetter, Uwe FuhrJournal of Personalized Medicine|February 23, 2024
Developing a Model for Quantifying QTc-Prolongation Risk to Enhance Medication Safety Assessment: A Retrospective AnalysisLuis Giovannoni, Gerd A Kullak-Ublick, Alexander JetterHepatology (Baltimore, Md.)|July 8, 2010
Pharmacogenetics of drug-induced liver injuryStefan Russmann, Alexander Jetter, Gerd A Kullak-UblickClinical Pharmacokinetics|June 22, 2005
Clinical pharmacokinetics of trospium chlorideOxana Doroshyenko, Alexander Jetter, Karl P Odenthal, et al.European Journal of Clinical Pharmacology|January 6, 2019
Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?Sven Frick, Daniel Müller, Gerd A Kullak-Ublick, et al.European Journal of Clinical Pharmacology|August 16, 2008
Mesalazine pharmacokinetics and NAT2 phenotypeHendrik Lück, Martina Kinzig, Alexander Jetter, et al.Pageof 6